178 related articles for article (PubMed ID: 13182238)
1. The use and action of chlorpromazine in psychoneuroses.
GARMANY G; MAY AR; FOLKSON A
Br Med J; 1954 Aug; 2(4885):439-41. PubMed ID: 13182238
[No Abstract] [Full Text] [Related]
2. Chlorpromazine in the treatment of neuropsychiatric disorders.
WINKELMAN NW
J Am Med Assoc; 1954 May; 155(1):18-21. PubMed ID: 13151880
[No Abstract] [Full Text] [Related]
3. [Largactil, a new vegetative damping agent in mental disorders].
STAEHELIN JE; KIELHOLZ P
Schweiz Med Wochenschr; 1953 Jun; 83(25):581-6. PubMed ID: 13076110
[No Abstract] [Full Text] [Related]
4. Preliminary observations on the psychiatric uses of chlorpromazine (largactil).
ANTON-STEPHENS D
J Ment Sci; 1954 Apr; 100(419):543-57. PubMed ID: 13175016
[No Abstract] [Full Text] [Related]
5. Effects of largactil in mental syndromes.
AZIMA H; OGLE W
Can Med Assoc J; 1954 Aug; 71(2):116-21. PubMed ID: 13182646
[No Abstract] [Full Text] [Related]
6. Effect of chlorpromazine on the behavior of chronically overactive psychotic patients.
ELKES J; ELKES C
Br Med J; 1954 Sep; 2(4887):560-5. PubMed ID: 13182280
[No Abstract] [Full Text] [Related]
7. [General and psychiatric points of view on the treatment with autonomic drugs].
LABHARDT F
Dermatologica; 1955 Oct; 111(4):177-85. PubMed ID: 13277366
[No Abstract] [Full Text] [Related]
8. Fatal case of toxic hepatitis implicating chlorpromazine.
BOARDMAN RH
Br Med J; 1954 Sep; 2(4887):579. PubMed ID: 13182288
[No Abstract] [Full Text] [Related]
9. New mood-changing drugs.
LEAKE CD
Ohio State Med J; 1956 Apr; 52(4):369-73. PubMed ID: 13309946
[No Abstract] [Full Text] [Related]
10. Experiences with chlorpromazine in the psychiatric and neurological clinic.
FLUGEL F
Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1954; 279():767-72. PubMed ID: 13234555
[No Abstract] [Full Text] [Related]
11. [Ganglioplegics in psychiatric therapy].
DESCHAMPS A
Sem Med; 1952 Oct; 28(38):650-3. PubMed ID: 13028540
[No Abstract] [Full Text] [Related]
12. The management of the neurotic and emotionally disturbed patient.
BROSIN HW
Chic Med; 1962 Jul; 65():13-7. PubMed ID: 13873501
[No Abstract] [Full Text] [Related]
13. [Use of 1522 CB in neuropsychiatry].
COIRAULT R; GIRARD V; ESCAFIT H; BENOIT P
Bull Mens Soc Med Mil Fr; 1955 Nov; 49(9):247-9. PubMed ID: 13304538
[No Abstract] [Full Text] [Related]
14. [Indications for chloropromazine therapy of neuropsychiatric disorders; practical use of its neuroplegic and psychoplegic properties; dosage].
SIGWALD J
Bull Med; 1953 Jun; 67(12):319-22. PubMed ID: 13082324
[No Abstract] [Full Text] [Related]
15. [Lytic therapy in the psychiatric clinic].
ENGELMEIER MP
Monatsschr Psychiatr Neurol; 1956; 131(2-3):89-150. PubMed ID: 13321865
[No Abstract] [Full Text] [Related]
16. [3-Chloro-10-(3'-dimethylaminopropyl)-phenothiazine hydrochloride in current neuro-psychiatry].
SIGWALD J; BOUTTIER D
Bull Mem Soc Med Hop Paris; 1953; 54(2):150-82. PubMed ID: 13065806
[No Abstract] [Full Text] [Related]
17. [Ganglioplegics in neuropsychiatry; review of literature and personal contribution].
GHERARDUCCI D; RICCI GC
G Psichiatr Neuropatol; 1953; 81(4):679-711. PubMed ID: 13142362
[No Abstract] [Full Text] [Related]
18. [Behavior of various autonomic functions in neuroplegic (largactil) therapy of psychoneuroses].
MONTANARI M; GIUA AM
Rass Studi Psichiatr; 1955; 44(4):433-75. PubMed ID: 13290099
[No Abstract] [Full Text] [Related]
19. Broad spectrum treatment of the neurotic and the borderline psychotic patient in office practice.
MORIARTY JD
J Neuropsychiatr; 1959; 1():112-7. PubMed ID: 14424159
[No Abstract] [Full Text] [Related]
20. [Psycho-autonomic alteration therapy with phenothiazin derivatives, with special reference to psychiatry].
WACHSMUTH R
Arztl Forsch; 1955 Jun; 9(6):261-74. PubMed ID: 14398519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
